BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 22956749)

  • 21. Molecular Identification, Genotyping, Phenotyping, and Antifungal Susceptibilities of Medically Important Trichosporon, Apiotrichum, and Cutaneotrichosporon Species.
    do Espírito Santo EPT; Monteiro RC; da Costa ARF; Marques-da-Silva SH
    Mycopathologia; 2020 Apr; 185(2):307-317. PubMed ID: 31776790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii.
    Li H; Lu Q; Wan Z; Zhang J
    Int J Antimicrob Agents; 2010 Jun; 35(6):550-2. PubMed ID: 20202797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A rare case of urinary tract infection due to Trichosporon asahii in a diabetic patient.
    Iken M; Belkouch A; Bellarj B; Naoui H; Boumhil L; El Bouti A; Jidane S; Belyamani L; Lmimouni B
    Pan Afr Med J; 2015; 20():127. PubMed ID: 26097631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular identification, genotyping, and drug susceptibility of the basidiomycetous yeast pathogen Trichosporon isolated from Turkish patients.
    Kalkanci A; Sugita T; Arikan S; Yucesoy M; Ener B; Otag F; Kiraz N; Kustimur S; Sancak B; Evci C; Emektas G
    Med Mycol; 2010 Feb; 48(1):141-6. PubMed ID: 19462333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital.
    Araujo Ribeiro M; Alastruey-Izquierdo A; Gomez-Lopez A; Rodriguez-Tudela JL; Cuenca-Estrella M
    Rev Iberoam Micol; 2008 Dec; 25(4):221-5. PubMed ID: 19071890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequence-based identification, genotyping and EUCAST antifungal susceptibilities of Trichosporon clinical isolates from Greece.
    Arabatzis M; Abel P; Kanellopoulou M; Adamou D; Alexandrou-Athanasoulis H; Stathi A; Platsouka E; Milioni A; Pangalis A; Velegraki A
    Clin Microbiol Infect; 2014 Aug; 20(8):777-83. PubMed ID: 24330082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of
    Francisco EC; de Almeida Junior JN; Queiroz-Telles F; Aquino VR; Mendes AVA; de Oliveira Silva M; Castro PTOE; Guimarães T; Ponzio V; Hahn RC; Chaves GM; Colombo AL
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318016
    [No Abstract]   [Full Text] [Related]  

  • 28. In Vitro Activity of Berberine Alone and in Combination with Antifungal Drugs Against Planktonic Forms and Biofilms of Trichosporon Asahii.
    Cong L; Liao Y; Yang S; Yang R
    Mycopathologia; 2017 Oct; 182(9-10):829-837. PubMed ID: 28144822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MALDI-TOF MS characterisation, genetic diversity and antifungal susceptibility of Trichosporon species from Iranian clinical samples.
    Ahangarkani F; Ilkit M; Vaseghi N; Zahedi N; Zomorodian K; Khodavaisy S; Afsarian MH; Abbasi K; de Groot T; Meis JF; Badali H
    Mycoses; 2021 Aug; 64(8):918-925. PubMed ID: 33998718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular and antifungal susceptibility study on trichosporonemia and emergence of Trichosporon mycotoxinivorans as a bloodstream pathogen.
    Dabas Y; Xess I; Kale P
    Med Mycol; 2017 Jul; 55(5):518-527. PubMed ID: 27816903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trichosporon asahii infection presenting as chronic meningo-ventriculitis and intra ventricular fungal ball: a case report and literature review.
    Kumar A; Udayakumaran S; Babu R; Rajamma BM; Prakash A; Panikar D; Karim S; Chowdhary A
    Mycoses; 2015 Feb; 58(2):99-103. PubMed ID: 25590228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Nosocomial urinary infection due to Trichosporon asahii. First two cases in Chile].
    Silva V; Zepeda G; Alvareda D
    Rev Iberoam Micol; 2003 Mar; 20(1):21-3. PubMed ID: 12825977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Head-to-head comparison of inhibitory and fungicidal activities of fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole against clinical isolates of Trichosporon asahii.
    Hazirolan G; Canton E; Sahin S; Arikan-Akdagli S
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4841-7. PubMed ID: 23877683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In Vitro Antifungal Activity of Sertraline and Synergistic Effects in Combination with Antifungal Drugs against Planktonic Forms and Biofilms of Clinical Trichosporon asahii Isolates.
    Cong L; Liao Y; Yang S; Yang R
    PLoS One; 2016; 11(12):e0167903. PubMed ID: 27930704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan.
    Ruan SY; Chien JY; Hsueh PR
    Clin Infect Dis; 2009 Jul; 49(1):e11-7. PubMed ID: 19489711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three-locus identification, genotyping, and antifungal susceptibilities of medically important Trichosporon species from China.
    Guo LN; Xiao M; Kong F; Chen SC; Wang H; Sorrell TC; Jiang W; Dou HT; Li RY; Xu YC
    J Clin Microbiol; 2011 Nov; 49(11):3805-11. PubMed ID: 21900517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mixed Infection of Toe Nail Caused by Trichosporon asahii and Rhodotorula mucilaginosa.
    Idris NFB; Huang G; Jia Q; Yuan L; Li Y; Tu Z
    Mycopathologia; 2020 Apr; 185(2):373-376. PubMed ID: 31760556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel silkworm infection model with fluorescence imaging using transgenic Trichosporon asahii expressing eGFP.
    Matsumoto Y; Yamazaki H; Yamasaki Y; Tateyama Y; Yamada T; Sugita T
    Sci Rep; 2020 Jul; 10(1):10991. PubMed ID: 32620930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activities of antifungal combinations against biofilms and planktonic forms of clinical Trichosporon asahii isolates.
    Liao Y; Yang S; Cong L; Lu X; Ao J; Yang R
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7615-6. PubMed ID: 25246408
    [No Abstract]   [Full Text] [Related]  

  • 40. Aspects related to biofilm production and antifungal susceptibility of clinically relevant yeasts of the genus Trichosporon.
    Lara BR; de Camargo BB; Paula CR; Monari GPM; Garces HG; Arnoni MV; Silveira M; Gimenes VMF; Leite Junior DP; Bonfietti LX; Oliveira L; Melhem MSC; Auler M; Ramos RTB; Dias ALT; Silva NC; Moreira D; Richini-Pereira VB; Anversa L; Ruiz LDS
    Med Mycol; 2023 Mar; 61(3):. PubMed ID: 36807459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.